Pfizer will charge health insurers as much as $1,390 for a five-day course of its Covid-19 treatment Paxlovid, the company told multiple news outlets, a price that comes as the drug’s distribution changes hands from the federal government to Pfizer’s commercial business—and as Pfizer predicts lower revenue from its coronavirus products.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,